$14.57
-0.20-1.35%
Last update: Nov 4, 7:10 PM
Dr Reddy's Laboratories Ltd
RDYNYSE
Dr Reddy's Laboratories (RDY) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '27 | Q1 '27 | Q4 '26 | Q3 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.16 | $0.17 | $0.09 | $0.16 |
| Actual | $0.12 | $0.06 | $0.03 | $0.16 |
| Surprise | -25.0% | -64.7% | -67.8% | +1.88% |
| Revenue | ||||
| Estimate | $980.6M | $925.5M | $866.1M | $978.1M |
| Actual | $905.0M | $853.0M | $821.8M | $978.8M |
| Surprise | -7.71% | -7.84% | -5.11% | +0.07% |
| Metric | Q3 '27E | Q4 '27E | Q1 '28E | Q2 '28E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.15 | $0.06 | $0.11 | $0.14 |
| Revenue | ||||
| Consensus | $1.00B | $875.6M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Oct 23, 2026 | $0.12 | $0.16 | -25.0 % |
| Q1 | Jul 22, 2026 | $0.06 | $0.17 | -64.7 % |
| Q4 | May 12, 2026 | $0.03 | $0.09 | -67.8 % |
| Q3 | Jan 20, 2026 | $0.16 | $0.16 | 1.88 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Oct 23, 2026 | $905.00M | $980.65M | -7.71 % |
| Q1 | Jul 22, 2026 | $853.00M | $925.53M | -7.84 % |
| Q4 | May 12, 2026 | $821.82M | $866.12M | -5.11 % |
| Q3 | Jan 20, 2026 | $978.82M | $978.10M | 0.07 % |
